Have a personal or library account? Click to login
Detection and management of perioperative blood glucose abnormalities† Cover

Detection and management of perioperative blood glucose abnormalities†

By: Yi Rong and  Wei-Bing Shuang  
Open Access
|Dec 2023

References

  1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from t5he International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:1–12.
  2. Galindo RJ, Fayfman M, Umpierrez GE. Perioperative management of hyperglycemia and diabetes in cardiac surgery patients. Endocrinol Metab Clin North Am. 2018;7:203–222.
  3. Jinjing W, Kang C, Xufei L, et al. Chinese clinical practice guidelines for perioperative blood glucose management. Diabetes Metab Res Rev. 2021;37:1–21.
  4. Chinese Diabetes Society, Chinese Medical Association. Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition). Int J Endocrinol Metab. 2021;41:482–548 (in Chinese).
  5. Han HW, Yue LQ, Wu FL, et al. Research progress of perioperative blood glucose management mode in diabetic patients. Chin Gen Pract Nurs. 2021;19:3779–3782 (in Chinese).
  6. Roth J, Sommerfeld O, Birkenfeld AL, et al. Blood sugar targets in surgical intensive care – management and special considerations in patients with diabetes. Dtsch Arztebl Int. 2021;118: 629–636.
  7. Barker P, Creasey PE, Dhatariya K, et al. Perioperative management of the surgical patient with diabetes 2015: association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2015;70:1427–1440.
  8. Zeng Y, Liu XN, Shen JH, et al. Analysis and evaluation of perioperative blood glucose management in fasting type 2 diabetic patients undergoing elective general anesthesia. Chin Pharm. 2021;30: 120–124 (in Chinese).
  9. Kopp Lugli A, Marti WR, Salm L, et al. The role of HbA1c as a positive perioperative predictor of surgical site and other postoperative infections: an explorative analysis in patients undergoing minor to major surgery. World J Surg. 2022;46:391–399.
  10. Halkos ME, Thourani VH, Lattouf OM, et al. Preoperative hemoglobin a1c predicts sternal wound infection after coronary artery bypass surgery with bilateral versus single internal thoracic artery grafts. Innovations (Phila). 2008;3:131–138.
  11. Dhinsa BS, Khan WS, Puri A. Management of the patient with diabetes in the perioperative period. J Perioper Pract. 2010;20:364–367.
  12. Cheisson G, Jacqueminet S, Cosson E, et al. Perioperative management of adult diabetic patients. Postoperative period. Anaesth Crit Care Pain Med. 2018;37:27–30.
  13. Mendez CE, Umpierrez G. Management of the hospitalized patient with type 1 diabetes mellitus. Hosp Pract. 2013;41:89–100.
  14. Rosenblatt SI, Dukatz T, Jahn R, et al. Insulin glargine dosing before next-day surgery: comparing three strategies. J Clin Anesth. 2012;24:610–617.
  15. Wang J. Application of integrated blood glucose management in cardiac surgery. Contemp Nurse. 2021;28:45–47 (in Chinese).
  16. Vongsumran N, Buranapin S, Manosroi W. Standardized glycemic management versus conventional glycemic management and postoperative outcomes in type 2 diabetes patients undergoing elective surgery. Diabetes Metab Syndr Obes. 2020;13:2593–2601.
  17. Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126:547–560.
  18. Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260–267.
  19. Mo GH, Cai XY, Ling, et al. Research progress of perioperative hyperglycemia in diabetic patients. Medical Recapitulate. 2019;25:1608–1613 (in Chinese).
  20. Boyle ME, Seifert KM, Beer KA, et al. Insulin pump therapy in the perioperative period: a review of care after implementation of institutional guidelines. J Diabetes Sci Technol. 2012;6:1016–1021.
  21. Cresci G. Targeting the use of specialized nutritional formulas in surgery and critical care. JPEN J Parenter Enteral Nutr. 2005;29:92–95.
  22. Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013;13:155–162.
  23. Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 2010;36:91–96.
  24. Lee H, Koh SO, Park MS. Higher dextrose delivery via TPN related to the development of hyperglycemia in non-diabetic critically ill patients. Nutr Res Pract. 2011;5:450–454.
  25. Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery. Br J Surg. 1994;81:59–63.
  26. Svanfeldt M, Thorell A, Hausel J, et al. Effect of “preoperative” oral carbohydrate treatment on insulin action – A randomised cross-over unblinded study in healthy subjects. Clin Nutr. 2005;24:815–821.
  27. Rehman HU, Mohammed K. Perioperative management of diabetic patients. Curr Surg. 2003;60:607–611.
  28. Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2010;87:64–68.
DOI: https://doi.org/10.2478/fon-2023-0040 | Journal eISSN: 2544-8994 | Journal ISSN: 2097-5368
Language: English
Page range: 373 - 380
Submitted on: Jan 18, 2023
Accepted on: Apr 12, 2023
Published on: Dec 18, 2023
Published by: Shanxi Medical Periodical Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Yi Rong, Wei-Bing Shuang, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution 4.0 License.